Tuesday, 19 January 2016

NEJM Week of 20th August 2015 (#4)

Professor Brian Andrews NEJM Recommendations
Week of the 20th August 2015 (#4)
University of Notre Dame Australia Fremantle

Perspective
GMOs, Herbicides, and Public Health

Very important article discussing genetically engineered crops which can withstand an array of carcinogens sprayed on the crops and when consumed will play a significant role in future human and animal carcinogenesis. This is a potential major public health issue. We must all be aware of what government and multinationals are inflicting on our environment for the generation of short term profits for a few. The medical profession must be proactive in this area and not act like ostriches.

EDITORIAL

Cancer Workup after Unprovoked Clot — Less Is More

http://www.nejm.org/doi/full/10.1056/NEJMe1507506

 

ORIGINAL ARTICLE

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

http://www.nejm.org/doi/full/10.1056/NEJMoa1506623

 

An Editorial and an Article discussing the frequency of primary malignancy within the first 12 months after an unprovoked DVT and how extensive an investigation the DVT patient should receive at onset.

The main problem is the age group of the patients studied with a mean age of 50 years.

 

REVIEW ARTICLE

Palliative Care for the Seriously Ill


An excellent overall review of palliative care. Make sure you review the Supplemental index for the management of specific problems encountered by the patient. Do not spend time considering the funding of palliative care in the US, as it differs from the Australian system.
This is more suited to MED400 students or MED300 students encountering this situation on the wards or in GP.

CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 26-2015 — A 9-Month-Old Girl with Recurrent Fevers


MED300 and MED400 students should read this article about fever in a child, presumed infectious in origin, but with no apparent site. Should a LP have been performed?

VIDEOS IN CLINICAL MEDICINE

Examination of the Retina

http://www.nejm.org/doi/full/10.1056/NEJMvcm1308125#t=article

 

An absolute requirement for all medical students. This is an area poorly performed by all students and interns, even if an ophthalmoscope is available.
This is a reminder that Videos in Clinical Medicine cover an extensive range of procedures and should be the “first port of call” for knowledge about any procedures.

IMAGES IN CLINICAL MEDICINE

Electrical Alternans with Pericardial Tamponade


After reviewing the case, the ECG and the echocardiogram, I now understand electrical alternans better than I had before. Should be reviewed by all medical students.
Perspective

Testosterone and “Age-Related Hypogonadism” — FDA Concerns

http://www.nejm.org/doi/full/10.1056/NEJMp1506632?query=featured_home

 

Discusses the indications of androgen replacement therapy in older males and how this is being misused in the US. Note, in the US, the average duration of use for “hypogonadism” is around 6 months!

 

Articles not considered to be of the highest value by the reviewing MED300 students, but which I feel may interest some students with a particular interest in basic research and its application to the future practice of clinical medicine

 

Perspective
FOCUS ON RESEARCH

Let's Not Put All Our Eggs in One Basket

http://www.nejm.org/doi/full/10.1056/NEJMp1508144

 

ORIGINAL ARTICLE

Vemurafenib in Multiple Nonmelanoma Cancers with BRAFV600 Mutations

http://www.nejm.org/doi/full/10.1056/NEJMoa1502309

 

Patients with metastatic melanoma and a BRAF activating mutation (a “driver” mutation) have a moderately increased survival rate if treated with a BRAF inhibitor, and slightly longer if a MEK inhibitor is also added (specific studies using advanced search in the journal for BRAF and melanoma). The obvious question is what happens to patients with other types of malignancies which also have a similar BRAF mutation when treated with specific inhibitors (in this case vemurafenib). The Perspective discusses “basket research” and the possible direction of research in an area which will become increasingly more common and controversial in future patient care, particularly in those patients who can afford very expensive, experimental treatment with a medication being used off-label.

 

CLINICAL IMPLICATIONS OF BASIC RESEARCH

Viral Vectors Take On HIV Infection

http://www.nejm.org/doi/full/10.1056/NEJMcibr1504232#t=article

 

A very interesting concept of transfecting cells in vivo using an adenoviral vector containing a protein which induces a broad neutralizing antibody against HIV gp120 in the host.

 

 


Other articles cover the treatment for hepatitis C in patients who are HIV positive and management of metastatic prostate cancer